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Abstract 
Background: To compare the ephedrine with 
lidocaine for reducing frequency of pain on propofol 
injection during elective surgeries. 
Methods:  In this randomized controlled trial  80 
patients were observed by taking 40 patients in each 
group, i.e. group A: ephedrine group and group 
B:lidocaine group. Patients with ASA–I (normal 
healthy patient), II (mild systemic disease with no 
functional limitation) aging between 20 and 40 years 
and opting for elective surgical procedures were 
included. The pain intensity was classified in four 
levels from no pain to severe pain. The frequencies 
of pain intensity were recorded during the injection 
period before the loss of consciousness according to 
the verbal rating scale (VRS) explained to patients at 
the preoperative visit. Chi square test was used to 
compare the frequency of pain in two groups, where 
p-value <0.05 was considered statistically significant. 
Effect modifiers i.e. the age, gender and ASA were 
controlled by stratification. The post stratification 
Chi-square test was applied keeping the p-value 
<0.05 as significant. 
Results: In Group A, 35% complained of severe 
pain, 42.5% had moderate pain,  22.5% had mild pain 
and no patients reported absence of pain as per our 
operational definition. In Group B 47.5% reported no 
pain during propofol injection, 40% complained of 
mild pain, 12.5% had moderate and no patients 
reported severe pain. The p-value is 0.00. 
Conclusion: Pretreatment with lidocaine resulted 
in significantly better pain control during propofol 
infusion than pretreatment with ephedrine.  
Key Words: Propofol, Procedural sedation, 
Ephedrine, Lidocaine 
 
Introduction 
Propofol (2,6-diisopropylphenol) is one of the most 
commonly used intravenous anaesthetic agent. It is 
preferred for its rapid onset, short duration of action, 
early recovery and minimal organ toxicity. It is 
commonly used for induction and maintenance of 
general anesthesia and sedation in intensive care units 
for its simplicity, stability and safety. 
Two main side effects of propofol use are pain on 
injection and hypotension. Incidence of pain on 
injection is 80-90% if injected in vein of dorsum of 
hand.1 Exact mechanism of pain is not known but 
many are proposed. Immediate pain results from 
action of phenol on vein and delayed pain by 
stimulation of nerve endings between intima and 
media by endothelium releasing kininogens.1 To date, 
many methods are proposed to eliminate its pain like 
adding lidocaine, injecting into larger veins like 
antecubital,changing temperature, diluting solution 
with 5% dextrose or intralipid2, varying speed of 
injection3, prior medication with metoclopramide, 
clonidine, ephedrine, magnesium sulphate, opioids, 
thiopentol, ketamine, paracetamol, flurbiprofen axetil, 
nitroglycerine and nitrous oxide, oxygen mixture4. 
New preparations like the one with sodium 
metabisulphite and one with 1% propofol in 16% 
polyoxyethylated castor oil also decrease pain. But 
none of these has resulted in reliable attenuation of 
pain, though lidocaine pretreatment is considered 
most effective so far.5 
Lidocaine is a local anesthetic agent. It reduces 
propofol injection pain by 30%.5Its exact mechanism of 
action is not known but is thought to be decreased 
neuronal conduction in peripheral nerves by 
attenuating the neuronal membrane's permeability to 
sodium ions or due to alteration in propofol's pH by 
adding HCl to it.3,5 Pain by lidocaine pretreatment 
with prior venous occlusion has failure rate of 24-37% 
and augments hypotension associated with propofol.5 
Ephedrine is a sympathomimetic, used for its effects to 
counter hypotension and bradycardia. It has both 
direct and indirect actions; direct by acting on alpha 
and beta receptors (more on beta) and indirect by 
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releasing norepinephrine from sympathetic nerve 
terminals. Cheong et al suggested in 2002 that 
ephedrine by its indirect action can reduce effect on 
bradykinin responsible for propofol injection pain.6 
Incidence of this pain reduction is 65%.2 It is also a 
venodilator and increases contact between propofol in 
aqueous phase and free nerve endings. It is also 
buffered with HCl resulting in altered pH and 
decreased pain.4 Agarwal et al. found that ephedrine 
pretreatment did not reduce pain so there are 
conflicting evidences about ephedrine’s role in 
reducing propofol injection pain. But as pain reduction 
by ephedrine is 65% as compared to lidocaine 30% 
with additional benefit of heamodynamic stability so 
aim of this study is to compare ephedrine with 
lidocaine for reducing pain on propofol injection 
during elective surgeries.4 
 
Patients and Methods 
This randomized controlled trial was conducted at 
Department of Anaesthesia, Holy Family Hospital, 
Rawalpindi, from August 2014  to February 2015. A 
total of 80 patients were observed by taking 40 patients 
in each group. Group A: ephedrine group. Group 
B:lidocaine group. The sample size was calculated by 
using WHO sample size calculator following are the 
calculations: Level of significance: 5% Power of test: 
80% Anticipated population proportion A is 65%12  
Anticipated population proportion B is 30%10.  Patients 
with ASA–I (normal healthy patient), II (mild systemic 
disease with no functional limitation), age ranged 20-
40 years and elective surgical procedures were 
included while patients patients with difficulty in 
communication e.g. psychiatric illness, dementia, 
aphasia etc, with history of adverse response or allergy 
to propofol, lidocaine or ephedrine,neurologic disease 
and cardiovascular disease were excluded. Cases in 
which vasopressor drugs are  contraindicated e.g. 
thyrotoxicosis, diabetes mellitus,  and hypertension of 
pregnancy and Patients receiving monoamine oxidase 
Inhibitors therapy were excluded. Patients were 
allocated to two groups “A”or “B” using computer 
generated random numbers. In both groups heart rate, 
non-invasive blood pressure, oxygen saturation and 
electrocardiography was monitored. Intravascular 
access in antecubital vein with one 18G cannula was 
established. Intravenous fluids administered to each 
patient as per requirement of patient and procedure. 
All the patients were preoxygenated with 100% 
oxygen via face mask for 3 minutes. Syringes of the 
pretreatment drugs, intravenous ephedrine 30 
microgram/kg labeled as A and intravenous lidocaine 
0.5 mg/kg  labeled as B prepared. The coded syringes 
were identical and the drugs prepared by the 
personnel not involved in the study. Drugs were 
handed over to the anesthetists for pretreatment who 
was unaware of the identity of the drug. So 
investigator who assess the patient response was also 
ignorant of the nature of the solution. All drugs were 
used within 15 minutes after preparation. Patients 
were randomly assigned into two groups to receive 
either drug. One minute after the administration of the 
test solution, the 1% solution of propofol at 2 mg/kg 
was given through the IV catheter while the running of 
IV infusion temporarily ceased. After the injection of 
propofol the crystalloids were administered. Patients 
were informed regarding the possible stinging 
sensation on  administration of a drug at the start of 
the anesthesia and they were asked about their pain 
during the injection period before the loss of 
consciousness according to the verbal rating scale 
(VRS) explained to patients at the preoperative visit. 
Furthermore, a blinded anesthesiologist evaluated the 
pain score  during propofol injection. Means and SD 
were calculated for continuous variables i.e. age, 
weight and height. Frequency and percentage were 
calculated for categorical variables i.e. gender, ASA 
and pain on injection. Chi square test was used to 
compare the frequency of pain in two groups, where 
p-value <0.05 was considered statistically significant. 
Effect modifiers i.e. the age, gender and ASA were 
controlled by stratification. The post stratification Chi-
square test was applied keeping the p-value <0.05 as 
significant. 
 
Results 
The patients included in the study were ASA-I and 
ASA-II. In group A, 25 (62.5%) patients were ASA I 
and 15 (37.5%) patients were ASA II. In group B, 22 
(55%) patients were ASA I while 18 (45%) patients 
were ASA II. In overall study population, 47 (58.75%) 
patients were ASA I while 33 (41.25%) were ASA II. 
Mean and standard deviation of their age, weight and 
height were calculated within each group as well as of 
the whole population (Table 1).Thirteen patients from 
group A complained of severe pain while no patient 
from group B complained of severe pain (Table 2).  
The p-value was found to be 0.00 (<<0.05). Post-
stratification Chi-square tests were applied and P-
value was found to be 0.00 (<<0.05). The results 
showed significant difference in the observed 
outcomes with pretreatment with lidocaine resulting 
in significantly better pain control than ephedrine 
during propofol infusion regardless of considered 
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effect modifiers, i.e. age, gender, height and ASA 
classification (Table 3). 
 
Table 1:  Demography of the study Population 
  Group A Group B 
  Male 
Fem-
ale Total Male 
Fem-
ale Total 
No 17 23 40 20 20 40 
Age 
(years) 
30.82 
± 7.03 
30.35 
± 7.08 
30.56 ± 
6.98 
33.95 ± 
9.5 
33.55 ± 
6.13 
33.75 
± 7.89 
Height 
(cm) 
170.7 
± 13.7 
152.6 
± 13.8 
166.0 ± 
14.2 
163.7 ± 
10.9 
159.8 ± 
14.4 
161.6 
± 13.2 
Weigh
t (kg) 
62.74 
± 9.56 
56.08 
± 8.33 
58.85 ± 
9.36 
65.95 ± 
10.34  
56.0± 
10.31 
60.98 
± 
11.37 
 
Table 2: Group wise frequency of pain intensity 
 Group A Group B 
 No Percentage No Percentage 
No pain 2 5 19 47.5 
Mild pain 9 22.5 16 40 
Moderate pain 16 40 5 12.5 
Severe pain 13 32.5 0 0 
 
Table 3: Pain frequency and percentages after 
treatment in both groups 
Pain 
Group A 
(Ephedrine) 
Group B 
(Lidocaine) 
p- value 
Yes 2 (5%) 21 (52.5%) 0.000 
(< 0.05) No 38 (96%) 19 (47.05%) 
 
Discussion 
The practice of acute care medicine often requires the 
performance of procedures that can cause pain and 
anxiety. Procedural sedation reduces the discomfort, 
apprehension, and potential unpleasant memories 
associated with such procedures and facilitates 
performance of the procedure. Procedural sedation 
involves the use of short-acting analgesic and sedative 
medications to enable clinicians to perform procedures 
effectively, while monitoring the patient closely for 
potential adverse effects. 
Propofol is an intravenous anaesthetic that is 
commonly used for sedation of the agitated adult 
intensive care unit (ICU) patient. It is particularly 
useful when rapid sedation and rapid awakening is 
desirable (e.g., patients who require frequent 
neurological examinations) because it has a short 
duration of effect.7,8 Propofol is a highly lipophilic 
phenol derivative that is insoluble in water. It is 
administered by continuous infusion in the ICU and 
not by intermittent infusion because it is associated 
with dose- and rate-dependent hypotension.9 Other 
main side effect of propofol use is pain during 
infusion. Incidence of pain on injection is 80-90% if 
injected in vein of dorsum of hand.1 Although, under 
the assumption of independent efficacy a third 
practical alternative could be pretreatment of the hand 
vein with lidocaine or ketamine and use of a propofol 
emulsion containing medium and long chain 
triglycerides.10,12 
The choice of drugs to be compared in this study, i.e. 
ephedrine and lidocaine followed from already 
existing studies, which show that ephedrine, by its 
indirect action, can reduce effect on bradykinin 
responsible for propofol injection pain.1,6 Furthermore, 
it has been reported that the two most efficacious 
interventions to reduce pain on injection of propofol 
were use of the antecubital vein, or pre-treatment 
using lidocaine in conjunction with venous occlusion 
when the hand vein was chosen. Although not the 
most effective intervention on its own, a small dose of 
opioids before induction halved the risk of pain from 
the injection and thus can generally be recommended 
unless contraindicated.10  Dependence of pain intensity 
during injection of microemulsion propofol on the 
amount of dose of lidocaine has been investigated in 
literature and it is established that increasing lidocaine 
dosage, within a dose range, significantly reduces pain 
during injection of microemulsion propofol.3,13 
Chi-square test was applied and p-value was found to 
be 0.000 (<0.05) implicating significant difference in 
the observed outcomes with pretreatment with 
lidocaine resulting in significantly better pain control 
than ephedrine during propofol infusion. The data 
was stratified with respect to effect modifiers like age, 
gender and ASA. The post stratification Chi-square 
test was applied and p-value was found to be 0.000 
(<0.05). Hence the significance of pain control 
treatment difference was found to be invariant of 
effect modifiers. 
The present study shows ephedrine not to be the most 
effective approach for reduction of pain caused by 
propofol injection. This is analogical to available 
literature, where it is reported that the  low dose 
ketamine or ephedrine pretreatment may prevent 
hypotension due to propofol induction but, despite the 
reduction in injection pain intensity after ketamine, 
both drugs were found to be ineffective in lowering 
the injection pain incidence.11,14 The study also found 
lidocaine to be effective measure in reducing the pain 
during propofol injection. Similar results have been 
deduced in other studies too, where lidocaine is found 
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to be the most effective measure to reduce the pain 
caused by the propofol injection.10 It is also known that 
increasing the dosage of lidocaine results in higher 
reduction in pain.3,15 
The natural intuition that may follow as a result of 
comparison of ephedrine and lidocaine is to consider 
their combination as a pain reducing measure. The 
idea has already been addressed in literature and 
shows that pretreatment with combination of small-
dose ephedrine and lidocaine could reduce the 
incidence and intensity of propofol-induced pain and 
also result in more stable hemodynamic profile, but 
however, the combination of two drugs failed to work 
better in further reduction of pain.1 
 
Conclusion 
Pretreatment with lidocaine results in significantly 
better pain control during propofol infusion than pre-
treatment with ephedrine.  
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